Evaluation of lead-iron-phosphate glass as a high-level waste form

The lead-iron-phosphate (Pb-Fe-P) glass developed at Oak Ridge National Laboratory was evaluated for its potential as an improvement over the current reference nuclear waste form, borosilicate (B-Si) glass. The evaluation was conducted as part of the Second Generation HLW Technology Subtask of the Nuclear Waste Treatment Program at Pacific Northwest Laboratory. The purpose of this work was to investigate possible alternatives to B-Si glass as second-generation waste forms. While vitreous Pb-Fe-P glass appears to have substantially better chemical durability than B-Si glass, severe crystallization or devitrification leading to deteriorated chemical durability would result if this glass were poured into large canisters as is the procedure with B-Si glass. Cesium leach rates from this crystallized material are orders of magnitude greater than those from B-Si glass. Therefore, to realize the potential performance advantages of the Pb-Fe-P material in a nuclear waste form, the processing method would have to cool the material rapidly to retain its vitreous structure

Waste package environment studies. FY 1984 annual report.

Tests were conducted by Pacific Northwest Laboratory in FY 1984 to examine the influence of heat and radiation on the chemical environment of a high-level nuclear waste package in a repository in salt and to determine the solubility of key radionuclides in site-specific brines. These tests are part of an ongoing effort by the Waste Package Program, whose objective is to help develop a data base on package components and system interactions necessary to qualify a nuclear waste package for geologic disposal. Specifically, tests performed in FY 1984 involved alpha and gamma radiolysis of brines, americium solubility in brines, the influence of heat and radiation on rock salt, and the influence of temperature on brine chemistry

A BAC Transgene Expressing Human CFTR under Control of Its Regulatory Elements Rescues Cftr Knockout Mice

Small-molecule modulators of cystic fibrosis transmembrane conductance regulator (CFTR) biology show promise in the treatment of cystic fibrosis (CF). A Cftr knockout (Cftr KO) mouse expressing mutants of human CFTR would advance in vivo testing of new modulators. A bacterial artificial chromosome (BAC) carrying the complete hCFTR gene including regulatory elements within 40.1 kb of DNA 5′ and 25 kb of DNA 3′ to the gene was used to generate founder mice expressing hCFTR. Whole genome sequencing indicated a single integration site on mouse chromosome 8 (8qB2) with ~6 gene copies. hCFTR+ offspring were bred to murine Cftr KO mice, producing hCFTR+/mCftr− (H+/m−) mice, which had normal survival, growth and goblet cell function as compared to wild-type (WT) mice. Expression studies showed hCFTR protein and transcripts in tissues typically expressing mCftr. Functionally, nasal potential difference and large intestinal short-circuit (Isc) responses to cAMP stimulation were similar in magnitude to WT mice, whereas small intestinal cAMP ΔIsc responses were reduced. A BAC transgenic mouse with functional hCFTR under control of its regulatory elements has been developed to enable the generation of mouse models of hCFTR mutations by gene editing for in vivo testing of new CF therapies. © 2019, The Author(s)